Allergy treatments now enter into a new era and year 2017 may witness a lot of innovative changes in this medical speciality. What the medical scientists and research centres now trying to or almost achieved is to stop the allergic reactions even before they start.
Taking the last century thousands of years before it, we can see that allergy treatments haven’t that much-advanced overtime with millions of people across the globe, at all times, suffered from allergy symptoms like wheezing, itching, and rashes etc. Ranging from minute symptoms to even ending up in death in severe cases, there are many types of exposures to allergens causing trouble ranging from weeds or pollen to food items or environmental conditions.
The scientists who are researching in-depth on human immune system have already are now somewhat successful in identifying the root cause of allergies. They have started on working the next generation of allergy therapies, which may not only help in simply treating the allergy symptoms, but may also be stopping the allergies on their tracks at the very primitive stages itself.
Many medical corporations and clinical research firms are now investing a huge amount of money into this field lately. No wonder this field is fast growing as the potential market is so huge almost 30 percent of the entire global population is suffering from various types of allergies.
The allergy therapies may become more specific and targeted in the next few years and more personalised to individual patients. There are many new inventions already started working at a trial basis like peanut desensitisation with the help of pills to slowly wean out the patient from the most common peanut allergy type of symptoms.
Scientists have identified that it is the peanut proteins which trigger the allergic reaction in humans and little capsules filled with this stuff is given to the patients. People may start by taking 0.5 mg of these peanut protein first and then gradually increasing over a time period about six months, which becomes equal to consuming a single peanut.
These capsules are now counted as the science’s answer to all previous efforts of allergists. The researchers working on the concept of desensitisation for tackling multiple allergies also at a time. There are many drugs scientists are excite about like omalizumab.
To understand this well, we need to have a clearly idea about the root cause of allergies. There are two types of immune cells in your system, which are known as ‘mast cells’ and ‘basophils’. There are identified as the major culprits behind allergic symptoms.
When someone encounters an external component, which is identified as an allergen, say for example peanut protein, which is an antibody named immunoglobulin E or medically IgE, instantly gets activated. This further stimulates mast cells and basophils in turn releasing a set of chemicals which provokes an allergic response to try and exorcise the allergen from the body.
new generation drugs which find curb the allergies are engineered to bind with
the human IgE and thereby blocking it from releasing the chemical substances
initiating the counter attack. Expectation is that almost 70 percent of the
allergic conditions can be improved or eradicated with this methodology;
however, this needed to be further streamlined and tested now.